Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Calliditas Therapeutics Ab ADR (NQ: CALT ) 40.00 UNCHANGED Last Price Updated: 3:53 PM EDT, Sep 20, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 40.00 Bid (Size) 20.29 (2) Ask (Size) 60.85 (2) Prev. Close 40.00 Today's Range 40.00 - 40.00 52wk Range 15.25 - 42.10 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Travere Stock Pops After Snagging Full Approval For Calliditas Rival In Kidney Disease September 06, 2024 The company previously had an accelerated approval for its IgA nephropathy treatment. Via Investor's Business Daily CALT Stock Earnings: Calliditas Therapeutics Misses EPS, Beats Revenue for Q2 2024 August 13, 2024 CALT stock results show that Calliditas Therapeutics missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. Via InvestorPlace Performance YTD +60.01% +60.01% 1 Month N/A N/A 3 Month +2.44% +2.44% 6 Month +98.71% +98.71% 1 Year +143.75% +143.75% More News Read More SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BALY, MRO, SHCR, CALT on Behalf of Shareholders July 27, 2024 From Halper Sadeh LLC Via GlobeNewswire Week In Review: MediLink And BioNTech Form $1.8 Billion ADC Partnership June 01, 2024 Via Talk Markets Critical Insights From Calliditas Therapeutics Analyst Ratings: What You Need To Know May 31, 2024 Via Benzinga Crude Oil Rises Sharply; Elbit Systems Shares Fall After Q1 Results May 28, 2024 Via Benzinga Exposures Fossil Fuels Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session May 28, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session May 28, 2024 Via Benzinga Asahi Kasei Makes $1.1B Offer For Swedish Drugmaker Calliditas Therapeutics, Enhancing Pharma Growth Strategy May 28, 2024 Via Benzinga Dow Dips Over 100 Points; GameStop Shares Spike higher May 28, 2024 Via Benzinga Topics Stocks Exposures US Equities Nvidia, Insmed, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday May 28, 2024 Via Benzinga CALT STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of Calliditas Therapeutics AB Is Fair to Shareholders May 28, 2024 From Halper Sadeh LLC Via Business Wire 12 Health Care Stocks Moving In Tuesday's Pre-Market Session May 28, 2024 Via Benzinga Why GameStop Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket May 28, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday May 28, 2024 Via InvestorPlace Apple To Rally Over 47%? Here Are 10 Top Analyst Forecasts For Friday May 24, 2024 Via Benzinga CALT Stock Earnings: Calliditas Therapeutics Misses EPS, Misses Revenue for Q1 2024 May 23, 2024 Via InvestorPlace 12 Health Care Stocks Moving In Thursday's Pre-Market Session May 23, 2024 Via Benzinga Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session April 29, 2024 Via Benzinga Palo Alto Networks Issues Weak Outlook, Joins Teladoc Health, SolarEdge Technologies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session February 21, 2024 Via Benzinga Topics Stocks Exposures US Equities What's Going On With Vera Therapeutics Stock Today? January 26, 2024 Via Benzinga Exposures Product Safety Why DouYu International Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session December 28, 2023 Via Benzinga NeoGenomics, Energy Fuels And Other Big Stocks Moving Lower On Thursday December 28, 2023 Via Benzinga Topics Intellectual Property Lawsuit Stocks Exposures Financial Intellectual Property Legal Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session December 21, 2023 Via Benzinga Calliditas Therapeutics Scores Complete FDA Approval, Broader Label For Lead Kidney Disease Drug December 21, 2023 Via Benzinga Exposures Product Safety Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
